IMR Press / FBL / Volume 11 / Issue 3 / DOI: 10.2741/2007

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Changes in gene expression with increased transglutaminase 2 in a SH-SY5Y cell line
Show Less
1 Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, MD, USA
2 Research Institute National Cancer Center, Goyang, Kyonggi-do, Republic of Korea
Front. Biosci. (Landmark Ed) 2006, 11(3), 2774–2781; https://doi.org/10.2741/2007
Published: 1 September 2006
Abstract

Previously we showed that the overexpression of transglutaminase 2 (TGase 2) resulted in activation of NF-κB through polymerization of I-κBα. To explore the pathway of TGase 2-mediated NF-κB activation, a transcriptomic microarray analysis was performed. In a SH-SY5Y cell line transfected with TGase 2, 24 genes were up-regulated at least 1.6-fold and 26 genes were down-regulated, as compared to the wild-type cell line. Detailed analysis resulted in the identification of target genes involved in regulating inflammation, including tribbles homolog 3, peroxiredoxin 4, neuropeptide Y, galanin, and vasoactive intestinal peptide. Our data demonstrate that the increase in TGase 2 in the neuroblastoma causes functional changes in transcriptional regulation, especially in genes associated with inflammation. These changes in gene expression caused by increases in TGase 2 activity may contribute to the pathophysiologic processes of inflammatory diseases.

Keywords
Inflammation
SH-SY5Y
neuroblastoma
transglutaminase 2
NF-κB
microarray
Share
Back to top